| Ticker | OGN |
|---|---|
| ISIN | US68622V1061 |
| Sector | Atención sanitaria |
| Mercado | NYSE |
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio. It al...
Organon&Company opera en el sector Healthcare, industria Drug Manufacturers - General.